CD163 and neoplasm: The higher levels of CD163 + immune cells (M2 macrophages) in the patients with longer survival could indicate signs of an immune-suppressed TME, as M2 macrophages are usually associated with immune suppression, increased tumor aggressiveness, early recurrence, and a poor prognosis [45, 46].